Skip to content
Search

Latest Stories

BREAKING: Birmingham pharmacist jailed for trafficking Class C drugs

A Birmingham pharmacist has been sentenced to 28 months in prison following an investigation by the Medicines and Healthcare Products Regulatory Agency (MHRA).

Sarfraz Hussain, 49, admitted to supply or intending to supply a total of 1,443,036 doses of controlled drugs worth around £854,000 to £1.4 million pleaded guilty at the Birmingham Crown Court in January.


The investigators found that Hussain, who operated three pharmacies out of Small Health, Erdington and Halesowen, never held a Home Office Controlled Drugs licence that allows to trade, import or export controlled drugs.

Despite this, he ordered large amounts of controlled drugs from legitimates suppliers, prompting the MHRA to inspect his Erdington pharmacy.

Hussain denied any wrongdoing during the initial questioning but further investigations revealed that from August 2015 to September 2016, he unlawfully supplied 31,537 packs of Class C drugs including Zopiclone, Diazepam, Nitrazepam, Zolpidem and Zopiclone.

MHRA enforcement officers seized 560,000 Diazepam, Nitrazepam and Zopiclone tablets from Hussain’s three pharmacies.

“It is a serious criminal offence to sell controlled drugs which are also prescription-only medicines without a prescription,” said Mark Jackson, MHRA Head of Enforcement.

“We work relentlessly with regulatory and law enforcement colleagues to identify and prosecute those involved.

“Those who sell medicines illegally are exploiting vulnerable people and have no regard for their health. Prescription-only medicines are potent and should only be taken under medical supervision” Jackson added.

More For You

Scottish community pharmacist working in high street pharmacy with supportive environment

The PDA wants investment to reach those who deliver services to patients every day

Pic credit: iStock

Funding boost in Scotland “needs to work for not just pharmacy owners but pharmacists too”, says PDA

An increase in funding for community pharmacies in Scotland needs to lead to a greater focus on supporting pharmacists rather than “simply sustain business models”, according to the Pharmacy Defence Association (PDA).

Earlier this week, Community Pharmacy Scotland (CPS) accepted the Scottish government’s initial financial offer for the 2025/26 fiscal year, securing a guaranteed minimum reimbursement of £120 million for community pharmacies — up from £110 million from 2024/25.

Keep ReadingShow less
GP surgery upgrades for annual appointments

The surgeries will have additional space to “see more patients, boost productivity and improve patient care”

Pic credit: iStock

GP surgery upgrades to create 8.3 million more annual appointments

Over 1,000 GP surgeries will have their premises modernised to meet the needs of a further 8.3 million appointments each year, the government has announced.

Backed by a cash injection of over £102 million, the surgeries will have additional space to “see more patients, boost productivity and improve patient care”.

Keep ReadingShow less
Wales boosts funding for pharmacy-led UTI and sore throat test services

The sore throat test (STTT) and treat service will be widely available

Pic credit: istock

Welsh pharmacies receive funding boost for clinical services

Two key clinical services will be available in 99 per cent of community pharmacies across Wales after a boost in funding.

The sore throat test (STTT) and treat service and the urinary tract infection (UTI) service have both benefitted from contractual negotiations between the Welsh Government and Community Pharmacy Wales (CPW).

Keep ReadingShow less
Paul Bennett
Paul Bennett, CEO, Royal Pharmaceutical Society
Paul Bennett, CEO, Royal Pharmaceutical Society

Pharmacists need to take advantage of independent prescribing pathways, says Bennett

Independent prescribing will be a “significant point” in the history of community pharmacy, according to Royal Pharmaceutical Society chief executive Paul Bennett.

Last month, the RPS announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

Keep ReadingShow less